Uncertainty analysis of tumour absorbed dose calculations in molecular radiotherapy.

Accuracy Dosimetry MRT PRRT RPT Radionuclide therapy Uncertainty analysis

Journal

EJNMMI physics
ISSN: 2197-7364
Titre abrégé: EJNMMI Phys
Pays: Germany
ID NLM: 101658952

Informations de publication

Date de publication:
12 Oct 2020
Historique:
received: 06 05 2020
accepted: 16 09 2020
entrez: 12 10 2020
pubmed: 13 10 2020
medline: 13 10 2020
Statut: epublish

Résumé

Internal dosimetry evaluation consists of a multi-step process ranging from imaging acquisition to absorbed dose calculations. Assessment of uncertainty is complicated and, for that reason, it is commonly ignored in clinical routine. However, it is essential for adequate interpretation of the results. Recently, the EANM published a practical guidance on uncertainty analysis for molecular radiotherapy based on the application of the law of propagation of uncertainty. In this study, we investigated the overall uncertainty on a sample of a patient following the EANM guidelines. The aim of this study was to provide an indication of the typical uncertainties that may be expected from performing dosimetry, to determine parameters that have the greatest effect on the accuracy of calculations and to consider the potential improvements that could be made if these effects were reduced. Absorbed doses and the relative uncertainties were calculated for a sample of 49 patients and a total of 154 tumours. A wide range of relative absorbed dose uncertainty values was observed (14-102%). Uncertainties associated with each quantity along the absorbed dose calculation chain (i.e. volume, recovery coefficient, calibration factor, activity, time-activity curve fitting, time-integrated activity and absorbed dose) were estimated. An equation was derived to describe the relationship between the uncertainty in the absorbed dose and the volume. The largest source of error was the VOI delineation. By postulating different values of FWHM, the impact of the imaging system spatial resolution on the uncertainties was investigated. To the best of our knowledge, this is the first analysis of uncertainty in molecular radiotherapy based on a cohort of clinical cases. Wide inter-lesion variability of absorbed dose uncertainty was observed. Hence, a proper assessment of the uncertainties associated with the calculations should be considered as a basic scientific standard. A model for a quick estimate of uncertainty without implementing the entire error propagation schema, which may be useful in clinical practice, was presented. Ameliorating spatial resolution may be in future the key factor for accurate absorbed dose assessment.

Sections du résumé

BACKGROUND BACKGROUND
Internal dosimetry evaluation consists of a multi-step process ranging from imaging acquisition to absorbed dose calculations. Assessment of uncertainty is complicated and, for that reason, it is commonly ignored in clinical routine. However, it is essential for adequate interpretation of the results. Recently, the EANM published a practical guidance on uncertainty analysis for molecular radiotherapy based on the application of the law of propagation of uncertainty. In this study, we investigated the overall uncertainty on a sample of a patient following the EANM guidelines. The aim of this study was to provide an indication of the typical uncertainties that may be expected from performing dosimetry, to determine parameters that have the greatest effect on the accuracy of calculations and to consider the potential improvements that could be made if these effects were reduced.
RESULTS RESULTS
Absorbed doses and the relative uncertainties were calculated for a sample of 49 patients and a total of 154 tumours. A wide range of relative absorbed dose uncertainty values was observed (14-102%). Uncertainties associated with each quantity along the absorbed dose calculation chain (i.e. volume, recovery coefficient, calibration factor, activity, time-activity curve fitting, time-integrated activity and absorbed dose) were estimated. An equation was derived to describe the relationship between the uncertainty in the absorbed dose and the volume. The largest source of error was the VOI delineation. By postulating different values of FWHM, the impact of the imaging system spatial resolution on the uncertainties was investigated.
DISCUSSION CONCLUSIONS
To the best of our knowledge, this is the first analysis of uncertainty in molecular radiotherapy based on a cohort of clinical cases. Wide inter-lesion variability of absorbed dose uncertainty was observed. Hence, a proper assessment of the uncertainties associated with the calculations should be considered as a basic scientific standard. A model for a quick estimate of uncertainty without implementing the entire error propagation schema, which may be useful in clinical practice, was presented. Ameliorating spatial resolution may be in future the key factor for accurate absorbed dose assessment.

Identifiants

pubmed: 33044651
doi: 10.1186/s40658-020-00328-5
pii: 10.1186/s40658-020-00328-5
pmc: PMC7550507
doi:

Types de publication

Journal Article

Langues

eng

Pagination

63

Subventions

Organisme : European Metrology Programme for Innovation and Research (EMPIR)
ID : 15HLT06 MRTDosimetry

Références

J Nucl Med. 2005 Jan;46 Suppl 1:99S-106S
pubmed: 15653658
J Nucl Med. 2017 Sep;58(Suppl 2):97S-103S
pubmed: 28864620
BMC Cancer. 2019 Aug 8;19(1):788
pubmed: 31395036
J Nucl Med. 2015 Feb;56(2):177-82
pubmed: 25593115
Eur J Nucl Med. 1997 Dec;24(12):1462-4
pubmed: 9391179
Semin Nucl Med. 2012 May;42(3):208-18
pubmed: 22475429
Phys Med. 2019 Jan;57:153-159
pubmed: 30738519
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):152-154
pubmed: 29080096
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1480-1489
pubmed: 28331954
EJNMMI Phys. 2015 Dec;2(1):24
pubmed: 26501825
EJNMMI Phys. 2018 Oct 15;5(1):25
pubmed: 30318563
Cancer Biother Radiopharm. 2007 Feb;22(1):166-74
pubmed: 17627426
Phys Med. 2018 Dec;56:41-49
pubmed: 30527088
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2456-2474
pubmed: 30218316
J Nucl Med. 2005 Jan;46 Suppl 1:62S-6S
pubmed: 15653653
EJNMMI Phys. 2017 Dec;4(1):7
pubmed: 28127694
J Nucl Med. 2018 Jan;59(1):75-81
pubmed: 28588150
Phys Med Biol. 2009 Nov 7;54(21):N501-7
pubmed: 19820266
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35
pubmed: 21892623
J Nucl Med. 2006 Sep;47(9):1467-75
pubmed: 16954555
Appl Radiat Isot. 2016 Jun;112:156-64
pubmed: 27064195
Phys Med. 2015 Feb;31(1):72-9
pubmed: 25457430
Clin Nucl Med. 2013 Mar;38(3):188-94
pubmed: 23412597
J Nucl Med. 2005 May;46(5):840-9
pubmed: 15872359
EJNMMI Phys. 2017 Dec;4(1):2
pubmed: 28063068
Cancer Biother Radiopharm. 2007 Jun;22(3):406-16
pubmed: 17651048
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
EJNMMI Phys. 2020 May 11;7(1):26
pubmed: 32394075
Phys Med Biol. 2015 Nov 7;60(21):8329-46
pubmed: 26458139
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1845-51
pubmed: 24615468
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):192-200
pubmed: 20799035
J Nucl Med. 2008 May;49(5):853-60
pubmed: 18413398

Auteurs

Domenico Finocchiaro (D)

Medical Physics Unit, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy.
Department of Physics and Astronomy, University of Bologna, Bologna, Italy.

Jonathan I Gear (JI)

The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Downs Road, Sutton, SM2 5PT, UK.

Federica Fioroni (F)

Medical Physics Unit, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy. Federica.Fioroni@ausl.re.it.

Glenn D Flux (GD)

The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Downs Road, Sutton, SM2 5PT, UK.

Iain Murray (I)

The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Downs Road, Sutton, SM2 5PT, UK.

Gastone Castellani (G)

Department of Physics and Astronomy, University of Bologna, Bologna, Italy.

Annibale Versari (A)

Nuclear Medicine Unit, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy.

Mauro Iori (M)

Medical Physics Unit, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy.

Elisa Grassi (E)

Medical Physics Unit, Azienda Unità Sanitaria Locale di Reggio Emilia - IRCCS, Reggio Emilia, Italy.

Classifications MeSH